SCM
Shah Capital Management Portfolio holdings
AUM
$514M
This Quarter Return
+9.15%
1 Year Return
+40.34%
3 Year Return
+230.54%
5 Year Return
+1,802.56%
10 Year Return
+5,221.11%
AUM
$423M
AUM Growth
+$423M
(+7.4%)
Cap. Flow
+$4.39M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
96.4%
Holding
15
New
–
Increased
5
Reduced
2
Closed
1
Top Buys
| 1 |
VEON
VEON
|
$6.82M |
| 2 |
Novavax
NVAX
|
$6.15M |
| 3 |
SOL
Emeren Group
SOL
|
$2.96M |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
$2.02M |
| 5 |
Cheer Holding
CHR
|
$516K |
Top Sells
| 1 |
New Oriental
EDU
|
$12.7M |
| 2 |
Dole
DOLE
|
$903K |
| 3 |
LifeMD
LFMD
|
$435K |
Sector Composition
| 1 | Consumer Staples | 23.23% |
| 2 | Communication Services | 20.14% |
| 3 | Energy | 12.95% |
| 4 | Technology | 12.7% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
New Oriental
EDU
$7.85B
| $94.6M | 22.39% | 1,616,282 -217,550 | -12% | -$12.7M |
|
|
2
VEON
VEON
$4.05B
| $75.6M | 17.9% | 3,879,138 +349,908 | +10% | +$6.82M |
|
|
SOL
3
Emeren Group
SOL
$93.4M
| $53.7M | 12.7% | 17,432,928 +961,125 | +6% | +$2.96M |
|
|
4
Novavax
NVAX
$1.21B
| $45.8M | 10.84% | 6,330,756 +850,000 | +16% | +$6.15M |
|
5
China Yuchai International
CYD
$1.25B
| $41.3M | 9.78% | 4,091,436 | – | – |
|
6
Genworth Financial
GNW
$3.52B
| $27.7M | 6.55% | 4,723,917 | – | – |
|
7
Antero Midstream
AM
$8.51B
| $25.2M | 5.95% | 2,100,646 | – | – |
|
8
Valaris
VAL
$3.54B
| $19.4M | 4.59% | 258,927 | – | – |
|
|
9
Vanguard Short-Term Treasury ETF
VGSH
$22.9B
| $13.9M | 3.29% | 241,223 +35,000 | +17% | +$2.02M |
|
10
Antero Resources
AR
$9.86B
| $10.2M | 2.4% | 400,000 | – | – |
|
11
Gannett
GCI
$603M
| $5.15M | 1.22% | 2,100,000 | – | – |
|
|
12
Cheer Holding
CHR
$13.8M
| $4.35M | 1.03% | 11,216,113 +1,329,628 | +13% | +$516K |
|
|
13
Dole
DOLE
$1.4B
| $3.56M | 0.84% | 307,065 -78,004 | -20% | -$903K |
|
14
iShares China Large-Cap ETF
FXI
$6.65B
| $2.18M | 0.51% | 82,039 | – | – |
|
|
15
LifeMD
LFMD
$294M
| – | – | -100,000 | Closed | -$435K |
|